AMENDMENT TO WARRANT TO PURCHASE COMMON STOCKWarrant to Purchase Common Stock • April 15th, 2014 • Q Therapeutics, Inc. • Pharmaceutical preparations • Delaware
This Amendment to Warrant to Purchase Common Stock (this “Amendment”) dated as of April 4, 2014, is made by and between Q Therapeutics, Inc. (formerly Q Holdings, Inc.), a Delaware corporation (the “Company”), and , (the “Warrant Holder”), and it hereby amends that certain Warrant to Purchase Common Stock of the Company (the “Existing Warrant”) originally issued October 13, 2011, No. QHA- .
WARRANT TO PURCHASE COMMON STOCK VOID AFTER 5:00 P.M., EASTERN TIME, ON THE EXPIRATION DATEWarrant to Purchase Common Stock • April 15th, 2014 • Q Therapeutics, Inc. • Pharmaceutical preparations
FOR VALUE RECEIVED, Q THERAPEUTICS, INC., a Delaware corporation (the “Company”), hereby agrees to sell upon the terms and on the conditions hereinafter set forth, but no later than 5:00 p.m., Mountain Time, on the Expiration Date (as hereinafter defined) to , or registered assigns (the “Holder”), under the terms as hereinafter set forth, up to a total of shares of common stock, $0.0001 par value (the “Common Stock”), of the Company (all such shares the “Warrant Stock”), at a purchase price of ONE DOLLAR ($1.00) per share (the “Warrant Price”), pursuant to this warrant (this “Warrant”). The number of shares of Warrant Stock to be so issued and the Warrant Price are subject to adjustment in certain events as hereinafter set forth.
REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • April 15th, 2014 • Q Therapeutics, Inc. • Pharmaceutical preparations • Utah
THIS REGISTRATION RIGHTS AGREEMENT (this “Agreement”) is made as of , 2014, among Q THERAPEUTICS, INC., a Delaware corporation (the “Company”), and each signatory hereto (each, an “Investor” and collectively, the “Investors”).
SUBSCRIPTION AGREEMENTSubscription Agreement • April 15th, 2014 • Q Therapeutics, Inc. • Pharmaceutical preparations • Utah
SUBSCRIPTION AGREEMENT made as of this day of , 2014 between Q THERAPEUTICS, INC., a Delaware corporation (the “Company”), and the undersigned (the “Subscriber”).
